Radiation and dual immunotherapy: a new hope for tough colon cancers?
NCT ID NCT06603818
Summary
This study aimed to test a new combination treatment for advanced colon cancer that has spread and is resistant to standard immunotherapies. It planned to give patients two immunotherapy drugs (tiragolumab and atezolizumab) along with a short, targeted course of radiation. The goal was to see if this three-part approach could better control the cancer's growth in patients who have run out of other options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.